Pharmaceutical Composition Comprising Crystalline (2s,3r,4s,5s,6r) 2 [4 Chloro 3 (4 Ethoxy Benzyl) Phenyl] 6 Hydroxymethyl 2 Methoxy Tetrahydro Pyran 3,4,5 Triol (S) Propylene Glycol Solvate - EP3363807

PATENT ANALYSIS

Patent Details

Grant Date
Nov 13, 2019

More patents of Astrazeneca Ab

Want to monitor this patent?

Feel free to send us a message here and we will get back to you